Energy companies Energy Transfer Equity and The Williams Companies, Inc., will divest Williams’ interest in an interstate natural gas pipeline to settle Federal Trade Commission charges that ETE’s proposed acquisition of Williams would likely harm competition in Florida.
According to the FTC’s complaint, the proposed merger, initially valued at $37.7 billion, would have reduced competition in the market for “firm” – i.e., guaranteed – pipeline capacity to deliver natural gas to points within the Florida peninsula.
In Florida, natural gas is extensively used for electric power generation, making competitive access to constant and reliable sources of supply critical. Florida’s electric power utilities are the state’s largest purchasers of natural gas.
The state, however, has virtually no local sources of natural gas production and no natural gas storage, making utilities and other customers dependent on pipeline-transported supply. As the FTC’s complaint alleges, the combination of ETE and Williams, as proposed, likely would have increased the price of transporting natural gas to utilities and other customers.
According to the FTC’s complaint, Dallas-based ETE owns a 50 percent share in Florida Gas Transmission LLC one of two interstate pipelines that serve the Florida peninsula. Tulsa-based Williams owns 50 percent of the other interstate pipeline – Gulfstream Natural Gas System L.L.C.. Absent a remedy, the acquisition would eliminate the competition between FGT and Gulfstream, which historically has enabled Florida customers to obtain lower transportation rates and better terms of service. It also would have resulted in a pipeline monopoly at many natural gas delivery points within the peninsula.
Full Content: Ohio
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas